Literature DB >> 15964546

Expression of developmentally regulated endothelial cell locus 1 was induced by tumor-derived factors including VEGF.

Masato Aoki1, Masahiko Kanamori, Kazuo Ohmori, Mikiro Takaishi, Nam-ho Huh, Shigeharu Nogami, Tomoatsu Kimura.   

Abstract

Developmentally regulated endothelial cell locus 1 (Del1) is a new angiogenic molecules expressed specifically in early embryonic endothelial cells. We investigated the relationship between Del1 and tumor cell-derived vascular endothelial growth factor (VEGF). Dunn osteosarcoma cells and high- and low-metastatic murine sarcoma cells did not express Del1. However, the expression of Del1 was observed in these primary tumor tissues and the pulmonary metastatic tissues after subcutaneous inoculation in vivo. Every tumor cell-conditioned medium containing VEGF induced the expression of Del1 in murine lung microvascular endothelial (MLE) cells, although control MLE cells did not express Del1. The anti-mouse VEGF monoclonal antibody inhibited the induction of the Del1 expression. In addition, mouse recombinant interleukin-1alpha and tumor necrosis factor-alpha also induced Del1 in MLE cells. Del1 may play an important role in tumor angiogenesis through the effects of tumor-derived factors including VEGF.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15964546     DOI: 10.1016/j.bbrc.2005.06.009

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas.

Authors:  Jian-Hua Luo; Baoguo Ren; Sergei Keryanov; George C Tseng; Uma N M Rao; Satdarshan P Monga; Steven Strom; Anthony J Demetris; Michael Nalesnik; Yan P Yu; Sarangarajan Ranganathan; George K Michalopoulos
Journal:  Hepatology       Date:  2006-10       Impact factor: 17.425

2.  Galectin-1 and its involvement in hepatocellular carcinoma aggressiveness.

Authors:  Daniela Spano; Roberta Russo; Vittorio Di Maso; Natalia Rosso; Luigi M Terracciano; Massimo Roncalli; Luigi Tornillo; Mario Capasso; Claudio Tiribelli; Achille Iolascon
Journal:  Mol Med       Date:  2009-12-21       Impact factor: 6.354

3.  integIRTy: a method to identify genes altered in cancer by accounting for multiple mechanisms of regulation using item response theory.

Authors:  Pan Tong; Kevin R Coombes
Journal:  Bioinformatics       Date:  2012-09-26       Impact factor: 6.937

Review 4.  SED1/MFG-E8: a bi-motif protein that orchestrates diverse cellular interactions.

Authors:  Adam Raymond; Michael A Ensslin; Barry D Shur
Journal:  J Cell Biochem       Date:  2009-04-15       Impact factor: 4.429

5.  Elevated autocrine EDIL3 protects hepatocellular carcinoma from anoikis through RGD-mediated integrin activation.

Authors:  Ming-Xuan Feng; Ming-Ze Ma; Ying Fu; Jun Li; Tao Wang; Feng Xue; Jian-Jun Zhang; Wen-Xin Qin; Jian-Ren Gu; Zhi-Gang Zhang; Qiang Xia
Journal:  Mol Cancer       Date:  2014-10-01       Impact factor: 27.401

6.  Identification of a Four-Gene-Based SERM Signature for Prognostic and Drug Sensitivity Prediction in Gastric Cancer.

Authors:  Xiya Jia; Bing Chen; Ziteng Li; Shenglin Huang; Siyuan Chen; Runye Zhou; Wanjing Feng; Hui Zhu; Xiaodong Zhu
Journal:  Front Oncol       Date:  2022-01-12       Impact factor: 6.244

7.  Downregulation of developmentally regulated endothelial cell locus-1 inhibits the growth of colon cancer.

Authors:  Xiaolong Zou; Haiquan Qiao; Xian Jiang; Xuesong Dong; Hongchi Jiang; Xueying Sun
Journal:  J Biomed Sci       Date:  2008-12-25       Impact factor: 8.410

8.  Effects of high intensity training and high volume training on endothelial microparticles and angiogenic growth factors.

Authors:  Patrick Wahl; Felix Jansen; Silvia Achtzehn; Theresa Schmitz; Wilhelm Bloch; Joachim Mester; Nikos Werner
Journal:  PLoS One       Date:  2014-04-25       Impact factor: 3.240

9.  Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.

Authors:  Shu-Heng Jiang; Yang Wang; Jian-Yu Yang; Jun Li; Ming-Xuan Feng; Ya-Hui Wang; Xiao-Mei Yang; Ping He; Guang-Ang Tian; Xiao-Xin Zhang; Qing Li; Xiao-Yan Cao; Yan-Miao Huo; Min-Wei Yang; Xue-Liang Fu; Jiao Li; De-Jun Liu; Miao Dai; Shan-Yun Wen; Jian-Ren Gu; Jie Hong; Rong Hua; Zhi-Gang Zhang; Yong-Wei Sun
Journal:  Oncotarget       Date:  2016-01-26
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.